Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Standard BioTools net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Standard BioTools Net Profit Margin 2010-2025 | LAB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Standard BioTools net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$35.1B
Tempus AI (TEM)	$7B
Hims & Hers Health (HIMS)	$6B
Inspire Medical Systems (INSP)	$4.5B
IRhythm Technologies (IRTC)	$3.2B
Privia Health (PRVA)	$2.9B
Schrodinger (SDGR)	$1.9B
Clover Health Investments (CLOV)	$1.8B
Enovis (ENOV)	$1.8B
Omnicell (OMCL)	$1.4B
Phreesia (PHR)	$1.4B
Azenta (AZTA)	$1.2B
10x Genomics (TXG)	$918M
Butterfly Network (BFLY)	$568M
Fulgent Genetics (FLGT)	$551M
Talkspace (TALK)	$450M
Veradigm (MDRX)	$449M
TruBridge (TBRG)	$363M
Claritev (CTEV)	$325M
Health Catalyst (HCAT)	$270M
Nyxoah SA (NYXH)	$206M
SOPHiA GENETICS SA (SOPH)	$189M
Pulmonx (LUNG)	$182M
American Well (AMWL)	$109M
EUDA Health Holdings (EUDA)	$100M
Retrieve Medical Holdings (RMHI)	$82M
MDxHealth SA (MDXH)	$76M
P3 Health Partners (PIII)	$66M
111 (YI)	$64M
CareCloud (CCLD)	$60M